Key Financials
 
Key financials

Selected Key Figures*

The fiscal year of HELLA ends on May 31.

* Please observe the remarks on the Yearly Figures.

02/05/2016
Sales
EBITDA
EBIT
Earning
Net financial dept
Equity

Yearly figures

Key figure
in € million
2017/2018 2016/2017 2015/2016
Sales 7,060 6,585 6,352
Change compared to previous period
[currency- and portfolio adjusted]
7% [9%] 4% [4%] 9% [8%]
EBIT [adjusted] 574 [581] 507 [534] 420 [476]
Change compared to previous period 13% [9%] 21% [12%] -2% [7%]
EBITDA [adjusted] 1,018 [1,024] 919 [946] 816 [858]
Change compared to previous period  11% [8%] 13% [10%] 7% [10%]
Earnings for the period 390 343 272
Change compared to previous period  14% 26% -8%
Earnings per share (in €) 3.50 3.08 2.42
Change compared to previous period  14% 27% -11%
R&D expenses 692 636 623
Change compared to previous period 9% 2% 15%
Free Cashflow [adjusted] 218 [241] 69 [149] 76 [155]
Net capital expediture 432 517 463
Change compared to previous period -17% 12% 33%
       
EBIT margin [adjusted] 8.1% [8.2%] 7.7% [8.1%] 6.6% [7.5%]
EBITDA margin [adjusted] 14.4% [14.5%] 14.0% [14.4%] 12.8% [13.5%]
R&D expenses in relation to sales 9.8% 9.7% 9.8%
Net capital expediture in relation to sales 6.1% 7.9% 7.3%
       
  May 31, 2018 May 31, 2017 May 31, 2016
Net financial debt 187 278 238
Net financial debt/EBITDA (last 12 months) 0.2x 0.3x 0.3x
Equity ratio 41.9% 39.5% 39.6%
Return on equity (last 12 months) 17.5% 17.3% 14.2%
Number of employees (headcount) 40,263 37,716 33,689
08/10/2018
 
 

Nine Month figures

Key Figures
in € million
Nine Months
FY 2018/2019
Nine Months
FY 2017/2018
Reported sales 5,169 5,130
Change compared to previous period
[currency- and portfolio-adjusted]
1% [6%] 7% [9%]
EBIT [adjusted] 649 [417] 404 [395]
Change compared to previous period 61% [6%] 16% [6%]
EBITDA [adjusted] 927 [693] 733 [721]
Change compared to previous period 26% [-4%] 14% [8%]
Earnings for the period 510 277
Change compared to previous period 84% 12%
Earnings per share (in €) 4.59 2.48
Change compared to previous period 85% 12%
R&D expenses 507 460
Change compared to previous period 10% 9%
Free Cashflow from operating activities [adjusted] 193 [210] 145 [179]
Net capital expenditure 358 312
Change compared to previous period 15% -5%
     
EBIT margin [adjusted] 12.6% [8.1%] 7.9% [8.2%]
EBITDA margin [adjusted] 17.9% [13.5%] 14.3% [14.9%]
R&D expenses in relation to sales 9.9% 9.5%
Net capital expenditure in relation to sales 6.9% 6.1%
     
  February 28, 2019 May 31, 2018
Net financial liquidity / debt 48 -187
Equity ratio 45.7% 41.9%
Return on equity  (last 12 months) 26.3% 17.5%
Number of employees (headcount) 39,327 40,263


Further information can be found in the selected financial information and in the further notes.

04/11/2019
 
 

Quarterly figures

Key Figures
in € million
3rd quarter
FY 2018/2019
3rd quarter
FY 2017/2018
Reported sales 1,619 1,678
Change compared to previous period
[currency- and portfolio-adjusted]
-3% [4%] 6% [9%]
EBIT [adjusted] 112 [115] 114 [109]
Change compared to previous period -2% [6%] 11% [4%]
EBITDA [adjusted] 205 [209] 228 [221]
Change compared to previous period -10% [-6%] 13% [8%]
Earnings for the period 66 78
Change compared to previous period -15% 5%
Earnings per share (in €) 0.60 0.70
Change compared to previous period -14% 7%
R&D expenses 167 154
Change compared to previous period 8% 8%
Free Cashflow from operating activities [adjusted] 46 [58] 72 [72]
Net capital expenditure 117 99
Change compared to previous period 17% -17%
     
EBIT margin [adjusted] 6.9% [7.1%] 6.8% [7.1%]
EBITDA margin [adjusted] 12.7% [12.9%] 13.6% [14.4%]
R&D expenses in relation to sales 10.3% 10.0%
Net capital expenditure in relation to sales 7.2% 5.9%


Further information can be found in the selected financial information and in the further notes.

04/11/2019
 
 

Sales by business segments

Sales by business segments

As of May 31, 2018

 
 

Regional market coverage

Regional market coverage

As of May 31, 2018

 
 

Employees by regions

Employees by regions

As of May 31, 2018

 
 
 
 
  • icon_druck
  • Youtube
  • linkedin-logo
 
 
 
Financial calendar
2019-08-09Annual Results 2018/19 Investor Call
10/17/2018
2019-09-26Results First Quarter 2019/20 Investor Call
10/17/2018
2019-09-27Annual General Meeting 2019
10/17/2018
 
07/28/2016
Contact

Dr. Kerstin Dodel
Investor Relations
Phone: +49 2941 38 1349
Fax: +49 2941 38 477099
Email: investor.relations@hella.com

 
08/30/2017
Stock Chart
 
05/30/2017